Back to search

Article

NCOA4 is a Prognostic Biomarker Associated with Immune Infiltrates in Glioblastoma

2022-03-02

Abstract excerpt

<h4>Background: </h4> Glioblastoma (GBM) is a malignant primary craniocerebral tumor with median survival of less than 15 months. Nuclear receptor coactivator 4 (NCOA4) can regulate the growth of various malignant tumors by participating in various biological processes. However, in glioblastoma, the specific regulatory role and mechanism of NCOA4 have not been clearly explained. <h4>Methods: </h4> We collected GBM...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ab2ff7f6-8ce1-5b94-be1d-bed0109bc4bb
DOI
10.21203/rs.3.rs-1326253/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
NCOA4 is a Prognostic Biomarker Associated with Immune Infiltrates in GlioblastomaDOI 10.21203/rs.3.rs-1326253/v2
Select a neighboring publication to make it the new centre.